NanoViricides, Inc.

NanoViricides, Inc.verified

NNVC

Price:

$1.22

Market Cap:

$21.80M

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the externa...[Read more]

Industry

Biotechnology

IPO Date

2005-10-26

Stock Exchange

AMEX

Ticker

NNVC

The Enterprise Value as of December 2025 (TTM) for NanoViricides, Inc. (NNVC) is -1125689200518.00

According to NanoViricides, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1125689200518.00. This represents a change of 300.02% compared to the average of -281407981694.42 of the last 4 quarters.

NanoViricides, Inc. (NNVC) Historical Enterprise Value (quarterly & annually)

How has NNVC Enterprise Value performed in the past?

The mean historical Enterprise Value of NanoViricides, Inc. over the last ten years is 29.20M. The current -1125689200518.00 Enterprise Value has changed -385455927.90% with respect to the historical average. Over the past ten years (40 quarters), NNVC's Enterprise Value was at its highest in in the March 2016 quarter at 109.29M. The Enterprise Value was at its lowest in in the September 2025 quarter at -1125686572740.00.

Quarterly (TTM)
Annual

Average

29.20M

Median

20.54M

Minimum

5.22M

Maximum

76.72M

NanoViricides, Inc. (NNVC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NanoViricides, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 228.78%

Maximum Annual Enterprise Value = 76.72M

Minimum Annual Increase = -74.42%

Minimum Annual Enterprise Value = 5.22M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202519.61M14.23%
202417.16M228.78%
20235.22M-32.32%
20227.71M-74.42%
202130.16M2.41%
202029.45M102.63%
201914.53M-32.35%
201821.48M-69.31%
201770.00M-8.76%
201676.72M4.30%

NanoViricides, Inc. (NNVC) Average Enterprise Value

How has NNVC Enterprise Value performed in the past?

The current Enterprise Value of NanoViricides, Inc. (NNVC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.00M

5-year avg

15.97M

10-year avg

29.20M

NanoViricides, Inc. (NNVC) Enterprise Value vs. Peers

How is NNVC’s Enterprise Value compared to its peers?

NanoViricides, Inc.’s Enterprise Value is less than Verrica Pharmaceuticals Inc. (72.93M), less than Jasper Therapeutics, Inc. (-7125220.00), less than SAB Biotherapeutics, Inc. (13.08M), less than Generation Bio Co. (71.40M), less than Evaxion Biotech A/S (29.95M), less than IGC Pharma, Inc. (25.07M), less than Q32 Bio Inc. (6.85M), less than MAIA Biotechnology, Inc. (34.29M), less than AN2 Therapeutics, Inc. (10.96M), less than Tenax Therapeutics, Inc. (-62802625.00),

Build a custom stock screener for NanoViricides, Inc. (NNVC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoViricides, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NanoViricides, Inc. (NNVC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NanoViricides, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NanoViricides, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NanoViricides, Inc. (NNVC)?

What is the 3-year average Enterprise Value for NanoViricides, Inc. (NNVC)?

What is the 5-year average Enterprise Value for NanoViricides, Inc. (NNVC)?

How does the current Enterprise Value for NanoViricides, Inc. (NNVC) compare to its historical average?